University of Wisconsin Milwaukee

UWM Digital Commons
Theses and Dissertations
May 2020

Photobiomodulation Modulates Bioenergetics and Oxidative
Stress in an in Vitro Model of Diabetic Retinopathy
Alexandria E. Hall
University of Wisconsin-Milwaukee

Follow this and additional works at: https://dc.uwm.edu/etd
Part of the Molecular Biology Commons

Recommended Citation
Hall, Alexandria E., "Photobiomodulation Modulates Bioenergetics and Oxidative Stress in an in Vitro
Model of Diabetic Retinopathy" (2020). Theses and Dissertations. 2667.
https://dc.uwm.edu/etd/2667

This Thesis is brought to you for free and open access by UWM Digital Commons. It has been accepted for
inclusion in Theses and Dissertations by an authorized administrator of UWM Digital Commons. For more
information, please contact scholarlycommunicationteam-group@uwm.edu.

PHOTOBIOMODULATION MODULATES BIOENERGETICS AND OXIDATIVE STRESS
IN AN IN VITRO MODEL OF DIABETIC RETINOPATHY

by
Alexandria Erin Hall

A Thesis Submitted in
Partial Fulfillment of the
Requirements for the Degree of
Master of Science
In Biomedical Sciences
at
The University of Wisconsin-Milwaukee
May 2020

ABSTRACT

PHOTOBIOMODULATION MODULATES BIOENERGETICS AND OXIDATIVE STRESS
IN AN IN VITRO MODEL OF DIABETIC RETINOPATHY
by Alexandria Hall
The University of Wisconsin-Milwaukee, 2020
Under the Supervision of Elizabeth Liedhegner, PhD and Janis Eells, PhD
Diabetic Retinopathy (DR) is the most common complication of diabetes mellitus and a
leading cause of blindness. The pathophysiology of DR is complicated, involving
mitochondrial dysfunction, oxidative stress, inflammation and vascular degeneration. The
most common therapeutic approach for DR includes the use anti-vascular endothelial
growth factor (VEGF) drugs to reduce vascular proliferation.

These treatments are

invasive, frequently ineffective and have numerous adverse effects. A non-invasive more
effective therapy is clearly needed. An alternative, non-invasive therapy using far-red
light (photobiomodulation, PBM) may be an improvement over current therapy. PBM has
documented efficacy in experimental and clinical studies of retinal disease including DR.
Müller glial cells play a critical role in retinal metabolism and are among the first cells to
demonstrate metabolic changes in response to retinal stress or disease and play an
important role in the pathophysiology of DR. High glucose treatment of Müller cells
increases the activity of Nuclear Factor Kappa beta (NFκB) resulting in DR-associated
protein synthesis. Previous studies in our laboratory have shown that that mimicking
hyperglycemia in cultured Müller cells activates the NFκB signaling pathway resulting in
an increase in intracellular adhesion molecule 1 (ICAM-1) and that 670 nm PBM blocks
this activation [Fisher, 2015].

However, the upstream mechanisms by which PBM
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reduces NFκB activity remain to be elucidated. We hypothesized that 670 nm
photobiomodulation would attenuate hyperglycemia-induced mitochondrial dysfunction
and protect against oxidative stress in a rat Müller glial cell model of diabetic retinopathy.
We tested this hypothesis in the following two aims: Specific Aim 1: Determine the
effects of 670 nm PBM on mitochondrial function in a cultured Müller cell model of DR at
24 hours. Specific Aim 2: Determine the effects of 670 nm PBM on oxidative stress and
glutathione status in a cultured Müller cell model of DR at 24 hours. We showed for the
first time that as little as 24 hour of exposure to high glucose conditions disrupted
mitochondrial metabolic activity, and decreased mitochondrial membrane potential, and
ATP production. A single treatment with 670 nm light (4.5 J/cm2) restored metabolic
activity, mitochondrial membrane potential and ATP production to values measured under
normal glucose conditions within one hour following treatment. We also showed that a
24-hour exposure to high glucose stimulated ROS production. These effects were also
reversed by a single treatment of 670 nm light within one hour. We conclude that this in
vitro model of diabetic retinopathy in a dish has considerable potential for use in the
development and testing of therapeutic agents to treat diabetic retinopathy. Our model
can assess disruptions in metabolic activity beginning with ROS generation and
mitochondrial redox changes culminating in increased production of angiogenic and
inflammatory mediators characteristic of diabetic retinopathy.
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Introduction
Diabetes mellitus
Diabetes mellitus is a metabolic disorder of multiple etiology characterized by chronic
hyperglycemia with disturbances of carbohydrate, fat and protein metabolism [8]. In
diabetes mellitus, the ability of the body to properly utilize the glucose is impaired resulting
in hyperglycemia. Glucose utilization is impaired due to either a lack/reduction in insulin
production (type I diabetes) secondary to the β-cell destruction or due to body's difficultly
in utilizing insulin (type II diabetes). The resulting hyperglycemia in both forms of diabetes
is key in the development of diabetic complications.
Diabetes is emerging as an epidemic of the 21st century. According to International
Diabetes Federation, every 7 seconds a person dies from diabetes. The number of
patients with this chronic disease world-wide is rising at an alarming rate. Across the
world, 382 million people have diabetes, and this number is projected to rise to 592 million
in less than 25 years [1]. In this life-long disease, sustained high circulating glucose
damages the vasculature resulting in chronic macro- and micro-vascular complications
throughout the body. Damage to the macro-vasculature increases the prevalence of heart
disease, stroke and peripheral arterial disease, and to the microvasculature, in
retinopathy, neuropathy and nephropathy in diabetic patients. As diabetes reaches
epidemic proportions, the need for the development and testing of safer and more
effective therapies for this disease and its complications is imperative.
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Diabetic retinopathy
Diabetic retinopathy is the most common microvascular complication of diabetes and a
leading cause of blindness in the United States [9]. The pathophysiology of diabetic
retinopathy is complicated, involving oxidative stress, elevated concentrations of vascular
endothelial growth factor (VEGF) and a breakdown of the inner blood-retinal barrier,
resulting in the extracellular fluid accumulation in macula resulting in disturbed vision [8,
18, 42, 47]. Control of diabetes-associated metabolic anomalies including hyperglycemia,
hypertension and hyperlipidemia play a major role in the development of microvascular
complications associated with diabetic retinopathy. Current interventions for diabetic
retinopathy include non-pharmacologic therapies (laser photocoagulation, vitrectomy)
and pharmacological therapies involving the intraocular injection of anti-angiogenic
agents or corticosteroids that target the excessive vascular growth and inflammation,
respectively [30, 47]. These interventions are invasive, expensive and only partially
effective.
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A Brief Review of Retinal Anatomy and Physiology
The fundamental organization of the retina is conserved across verteb rates. The retina
contains five major neuronal cell classes
(photoreceptors, bipolar cells, amacrine cells,
horizontal cells and retinal ganglion cells) with
two prominent support cells, Müller glial cells
and retinal pigment epithelial cells, providing
metabolic and homeostatic support (Figure 1)
[6, 8]. As light enters the eye, rod and cone
photoreceptors convert light energy into
neural activity. This conversion is made
possible by light-sensitive pigments located
on the outer segments of the photoreceptor
cells.

The

photoreceptors

synapse

with

bipolar cells. Bipolar cells synapse the retinal
ganglion cell which transmit the visual signal
along their axons (optic nerve) and ultimately, to
the brain (Figure 1) [1]. The retinal pigment

Figure 1: The complexity of the retinal layers
from the inner retina (top) to the outer
retina (bottom). Retinal cells communicate
with each other to transmit a signal to the
brain to produce vision. Adapted from
Ryskamp et al. 2014

epithelium envelopes the photoreceptors facilitating the diffusion of nutrients, key
metabolites and oxygen from the choroidal vessels. Horizontal cells, amacrine cells and
Müller cells mediate and support the synapses between retinal neurons through the
collection and synthesis of glutamate (Figure 1) [1, 48]. The Müller cell has processes
that span through the inner- and most of the outer-retina which is unique to this cell type.
3

These processes allow Müller cell to maintain multiple synapses with different cells
throughout the retina. Pericytes surround the vascular endothelial cells in all retinal layers,
forming the blood-retinal barrier (Figure 1) [1, 48].
The retina is the highest oxygen-consuming organ in the human body. Inner retinal
neurons have the highest metabolic rate of all central nervous tissue, and the oxygen
consumption rate of the photoreceptors is, uniquely, several times higher again. The inner
segments of the photoreceptor cells are rich in mitochondria providing the ATP required
by the ionic pumps which depolarize the cell, driving the ‘dark current’. Modulation of the
dark current by light is the beginning of vision [48]. As a result, photoreceptors consume
more oxygen per gram of tissue weight than any cell in the body [48,49]. This intense
oxidative phosphorylation in their inner segments, coupled with high concentrations of
polyunsaturated fatty acids in their outer segments naturally renders the retina
susceptible to oxidative stress and lipid peroxidation [48]. The retina also contains
abundant photosensitizers and is exposed to visible light [49].

Normally, oxidative

damage is minimized by endogenous antioxidants and repair systems. With aging and
retinal disease, there is an increase in mitochondrial dysfunction and oxidative damage
and corresponding decrements in antioxidants and repair systems, resulting in retinal
dysfunction and retinal cell loss, leading to visual impairment [48].
In DR, chronic hyperglycemia promotes metabolic dysfunction culminating in excess
production of ROS in retinal cells [12, 22, 33, 38, 39, 45]. This surplus of ROS activates
pathogenic signaling pathways in the retina leading to inflammation, angiogenesis, and
disease. In addition, high concentrations of ROS deplete antioxidant defense systems,
subjecting the retina to additional oxidative damage. Although microvascular changes are
4

integral to diabetic retinopathy, the neural retina is also profoundly affected. Experimental
and clinical studies have provided evidence that neural retinal defects are among the
earliest detectable changes in diabetes [8]. Among the retinal cell types susceptible to
hyperglycemia-induced oxidative stress are retinal ganglion cells, photoreceptor cells,
retinal pigment epithelial cells, pericytes and Müller glial cells [10, 12, 22, 38, 39, 47].
Furthermore, in vitro and in vivo studies have shown that Müller glial cells play a very
important role in the pathogenesis of diabetic retinopathy [6, 10, 23].

Müller glial cells
Müller cells are the principle glia of the retina. Müller glia are the only cells that span the
retina and have intimate contact with both the retinal blood vessels and retinal neurons
[6]. Müller cells serve a number of essential functions in the healthy retina including the
uptake and recycling of neurotransmitters, retinoic acid compounds, and ions (such as
potassium K+), the control of metabolism and supply of nutrients or the retina, and the
regulation of blood flow and maintenance of the blood retinal barrier [33, 34]. In DR,
hyperglycemia-induced retinal injury activates Müller cells resulting in increased
synthesis of survival factors [13, 33]. These factors promote a stress response by
activating intracellular pathogenic pathways that promote activation of the inflammatory
transcription factor, NFKB leading to the production of ICAM and VEGF, responsible for
angiogenesis in DR [8, 10, 13, 18, 58]. Previous in vitro studies in other laboratories as
well as our own lab have shown that Müller cells upregulate NFKB and VEGF when
exposed to high glucose media [10, 3, Fisher, 2015, Hall, 2017].

Müller glial cells

significantly contribute to diabetic retinopathy, especially through the secretion of VEGF
5

[4, 7, 10, 13, 34, 40, 43, 44]. VEGF promotes to growth of blood vessels throughout the
retina which obstruct and physically block vision. For this reason, cultured Müller glial
cells have been widely utilized to study diabetic retinopathy and have become a wellestablished model of this disease state.
DR Pathogenesis
The pathogenesis of diabetic retinopathy is complex involving the disruption of multiple
intracellular pathways [8, 18]. Early pathologic changes observed in diabetic retinopathy
include mitochondrial dysfunction, oxidative stress and inflammation [22, 24]. Oxidative
stress results from increased production of reactive oxygen species (ROS), including
superoxide and hydrogen peroxide (Figure 2) [3, 19, 24]. ROS oxidize intracellular
proteins, lipids and nucleic acids disrupting normal signaling and culminating in disease.
Under physiological conditions, small amounts of superoxide leak from the electron
transport chain and are converted to hydrogen peroxide by mitochondrial superoxide
dismutase (Figure 2) [3, 24]. Hydrogen peroxide diffuses out of the mitochondria into the
cytosol and serves an important signaling molecule.

Intracellular ROS concentrations

are regulated by a complex array of antioxidant systems to maintain low intracellular ROS
concentrations [2, 3, 25, 31]. Under hyperglycemic conditions, the excess production of
ROS overwhelms the antioxidant systems to a threshold resulting in oxidative stress
(Figure 2) [22, 25, 34, 37].
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Figure 2: Mechanism of ROS production and ROS action in normal and pathogenic
environments. Saunders et al. 2010

A major source of the excess ROS production under hyperglycemic conditions is the
mitochondrial electron transport chain (ETC) (Figure 3) [3, 29, 31, 42, 47]. Under normal
physiological conditions, electrons are donated to complex I or complex II of the ETC and
are then passed on to coenzyme Q, complex III, cytochrome c, complex IV and ultimately
to molecular oxygen, the final electron acceptor (Figure 3). The transfer of electrons
generates a proton gradient across the mitochondrial intermembrane which drives
synthesis of ATP by ATP synthase. During this process, small amounts of superoxide
7

are produced, but are easily cleared by the cell via antioxidant defense mechanisms
(Figure 3) [3].

Figure 3: The mitochondrial electron transport chain and production of ROS by electrons
escaping coenzyme Q. O2-: superoxide; H2O2: hydrogen peroxide; SOD: superoxide
dismutase. Bigarella et al. 2014

In DR, chronic hyperglycemia disrupts the mitochondrial ETC. Increased glucose
metabolism results in more electrons passing down the ETC. Excess electrons
overwhelm coenzyme Q. Those electrons fail to be transferred to complex III and are
instead dispensed prematurely onto molecular oxygen, creating superoxide (Figure 3) [3,
16]. Superoxide is quickly converted by superoxide dismutase into hydrogen peroxide.
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Therefore, mitochondria are a major source of ROS production [3, 45, 47] and
mitochondrial dysfunction is a major factor in DR pathogenesis.
Cells susceptible to retinal injury have been shown to respond to chronic hyperglycemia,
mitochondrial dysfunction, and ROS via five key pathogenic pathways: the polyol
pathway, the advanced glycosylated end products (AGEs) pathway, the protein kinase C
(PKC) pathway, the hexamine pathway and the angiotensin II (AII) pathway (Figure 4) [8].
Molecular Mechanisms of DR
High glucose alters a number of metabolic pathways; some of the major pathways
implicated in the development of retinopathy are PKC activation, accumulation of AGEs
and inflammatory mediators, polyol pathway, oxidative stress and activation of the
hexosamine pathway (Figure 4) [8, 18]. Experimental models have shown that in the
etiology of this progressive disease, activation of NADPH oxidase (Nox) increases
cytosolic reactive oxygen species (ROS), and sustained accumulation of ROS damages
mitochondria further increasing oxidative stress [17, 18]. Superoxide radicals produced
by the mitochondrial electron transport chain activate these major pathways, and
activation, in turn, can damage the mitochondria propagating the vicious cycle of ROS
(Figure 4) [46, 47]. Any connection between a particular metabolic abnormality and the
development of diabetic retinopathy, however, is largely speculative, and it is highly likely
that no single metabolic abnormality could be the sole cause of the development of
diabetic retinopathy. Furthermore, the role of other systemic factors including
hyperlipidemia and hypertension in retinal damage and pathology also remains underinvestigated.
9

DR

Figure 4: The major pathways involved in DR pathogenesis. Diabetes increases
hyperglycemia and activates five major pathogenic pathways. These pathways are
caused by and lead to oxidative stress, mitochondrial dysfunction, and inflammation resulting
in DR-associated protein synthesis, angiogenesis and DR. AGE: advanced glycosylated end
products; PKC: Protein kinase C; AII: Angiotensin II. Adapted from Wang, J. 2017

In the diabetic retina, the polyol and hexamine pathways contribute to oxidative stress by
oxidation of proteins and depletion of antioxidants within the cell (Figure 4) [8, 15, 46].
The activation of the AGE, angiotensin II, and PKC pathways result in increased ROS,
NFKB activity, and VEGF production [8, 46]. Upregulation of NFKB activity (Figure 5)
[Fisher, 2015] increases cytokine production leading to retinal inflammation,
angiogenesis, and retinal pathogenesis [8,18, 26, 42]. Angiogenesis in the diabetic retina
is attributed to elevated concentrations of VEGF, found late in disease. The development
of new blood vessels physically block vision and appear as black spots to DR patients.
These blood vessels are weak and prone to rupture as retinal disease progresses.
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Ruptured vessels result in a significant breakdown of the blood-retinal barrier and
potentiate complete blindness in patients with DR [8, 18, 42].
Previous studies in our laboratory tested the hypothesis that 670 nm PBM would inhibit
the activation of NFκB resulting in a reduction in the production two key cytokines involved
in vascular proliferation and immune dysregulation, VEGF and ICAM-1. These studies
employed an in vitro model system of cultured retinal Müller glial cells grown in normal
(5mM) or high (25mM) glucose conditions to simulate normoglycemia and hyperglycemia,
respectively. Cultures were treated with 670 nm LED light (180 sec at 25 mW/cm2; 4.5
J/cm2) or no light (sham) for three days (Figure 6). NFκB activity and ICAM-1
concentrations were significantly increased under high glucose conditions (Figure 5,
Figure 6). 670 nm PBM restored NFκB activity to values measured under normoglycemic
condition levels. 670 PBM also suppressed the production of the downstream
inflammatory and angiogenic mediators, ICAM-1 and VEGF, respectively.

These data

support our central hypothesis that mimicking hyperglycemia in an in vitro model of
diabetes retinopathy activates the NFκB signaling pathway resulting in an increase in
ICAM-1 and VEGF and that 670 nm PBM blocks this activation (Figure 5, Figure 6).
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Figure 5: 670 nm Light Treatment Diminishes NFκB Activity under High Glucose
Conditions In Müller Cells. Müller cells were cultured in either normal glucose or high
glucose medium for 72 hours. 670nm or sham control was applied to the cells at 4.5 J/cm2
daily. NFκB activity was analyzed via reporter gene assay, normalized to the transfection
control, Renilla. *** p<0.001 n=4, performed in duplicate. (Fisher Thesis)
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Figure 6: 670 nm Light Treatment Diminishes downstream products of NFκB activity. Müller
cells were cultured in either normal glucose or high glucose medium for 72 hours. 670nm or
sham control was applied to the cells at 4.5 J/cm2 daily while in culture. A. VEGF mRNA was
analyzed via qPCR and normalized to actin. mRNA levels were calculated by DDCt and
normalized to Normal glucose sham, n=2, done in duplicate. B. ICAM was analyzed via western
blot and normalized to GAPDH as the loading control via ImageJ. Inset includes a representative
western blot image, n=4. * p<0.05, ** p<0.01, *** p<0.001. [Fisher 2015, Hall 2015]

The objective of the present investigation was to use this Müller glial cell in vitro model of
diabetic retinopathy to elucidate the upstream signaling mechanisms that culminate in the
activation of NFκB activity and subsequent increase in the downstream mediators of
inflammatory signaling, ICAM-1 and VEGF. Our second objective was to determine the
effect of 670 nm PBM on these signaling mechanisms.

Mitochondria and ROS Production
Mitochondria are essential for cell function and cell survival, including energy production
and regulation of cell metabolism and apoptosis [42, 52]. Mitochondria are also a primary
source of ROS, generated as a byproduct of the electron transport chain (ETC) (Figure
4) [3, 29, 31, 42, 45, 47]. The ETC produces about 85-90% of total ROS within the cell [3,
13

42]. Mitochondria are also a target of ROS in disease [2, 42]. Hydrogen peroxide causes
structural damage to this organelle [31, 42], further inducing mitochondrial dysfunction.
However, the cause of mitochondrial dysfunction in a diabetic state is unclear. Some
studies suggest that the increased glucose concentration overwhelms the electron
transport chain by increasing the rate of oxidative phosphorylation [8], generating ROS.
Other studies suggest that mitochondrial DNA is damaged, resulting in dysfunctional
proteins that will form essential sections of the ETC complexes, also causing excess ROS
and mitochondrial dysfunction [7]. Impaired mitochondrial function is commonly observed
in chronic diseases including diabetes mellitus [16, 17, 18, 31, 52].

Mitochondrial

dysfunction under pathological conditions is promoted by increased oxidative stress,
which can stimulate post-translational modifications of mitochondrial proteins and/or
oxidative damage to mitochondrial DNA and lipids [12].
Mitochondrial morphology is essential in function of the mitochondria and the whole cell.
In dysfunctional mitochondria, morphology is altered, mitochondrial membrane potential
is reduced, and the integrity of the mitochondrial membrane is disrupted [17, 25]. When
the integrity of the mitochondrial membrane fails, mitochondria send apoptotic signals that
lead to pore formation in the mitochondrial membrane to induce apoptosis. This
mitochondrial permeability transition pore forms a pore in the inner mitochondrial
membrane promoting the release of cytochrome c from the inner membrane space into
the cytosol [38, 39, 45]. This significantly disrupts cell metabolic activity and initiates
apoptosis via the mitochondrial apoptotic pathway; contributing to DR pathogenesis.
Oxygen consumption is another measure of mitochondrial function. As oxygen is the final
electron acceptor of the ETC; the reduction of oxygen to water can be measured. Maximal
14

and steady state oxygen consumption was measured in high and normal glucose
conditions at three- and six-days post exposure [39]. At day-three, rat retinal endothelial
cells were not affected by glucose concentration. However, after six days post high
glucose exposure, retinal endothelial cells significantly decreased both steady state and
maximal oxygen consumption [39]. These results were independent of the number of
mitochondria present in the cell [39], indicating a decrease in mitochondrial function in
retinal endothelial cells exposed to high glucose conditions.

Role of Mitochondria in Müller Glial Cells

Retinal Müller cells play a crucial role in maintaining retinal homeostasis [6]. Moreover,
Müller cell function requires considerable energy production. Although previous literature
has primarily emphasized the importance of glycolysis as the main energy provider,
recent studies highlight the need of mitochondrial ATP production to maintain Müller cell
function especially under conditions of chronic oxidative stress [10, 19, 34, 40].
Therefore, the mitochondria in Müller cells play an important role in disease pathogenesis.
Under high glucose conditions, we anticipated metabolic activity to decrease due to
stress. Devi et al. (2012) found that cytochrome c oxidase remains active after prolonged
high glucose exposure in retinal Müller cells [10]. This indicates that the cells and
mitochondria remain functional under chronic hyperglycemic conditions and may activate
mechanisms to survive.
Interestingly, Müller cells in high glucose conditions decreased intracellular ROS levels
at four hours, however, was increased at day-three [10]. ATP generation increased at four
15

hours, and then decreased after 24 hours [10] and remained low post high glucose
exposure [10]. These results suggest that initial exposure to high glucose levels promotes
the modulation of ATP and ROS levels around 24 hours. This may lead to an increase in
antioxidant defense activity to compensate and decrease ROS levels. Eventually the
antioxidant systems may become overburdened resulting in increased and persistent
levels of intracellular ROS and decreased ATP generation.
In Müller glial cells exposed to high glucose conditions for seven days, the mitochondrial
morphology was significantly disrupted compared to cells grown in normal medium [37].
Further, these cells exhibited a decrease in oxygen consumption rate and extracellular
acidification (glycolysis) and an increase in mitochondrial membrane potential and
cytochrome c release [37]. With chronic exposure, Müller cells produce DR-associated
proteins leading to disease. Therefore, in a Müller cell model of DR, compromised
mitochondrial respiration leads to DR.
In the Müller cell model system, it is currently unknown whether mitochondrial dysfunction
or ROS production initiates the disease pathway. However, it is apparent that oxidative
stress affects mitochondrial function in Müller cells in high glucose conditions. ROS
accumulation correlates with a decrease in antioxidant defense systems [10]. Therefore,
prolonged exposure to high glucose conditions leads to mitochondrial dysfunction and
increased ROS. Excess ROS depletes the available antioxidants, leading to further
increased ROS within Müller cells, and disease.
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Antioxidant Defense Systems
Under normal physiological conditions, low levels of ROS act as signaling molecules that
are kept in balance by intracellular antioxidant defense systems. In disease, oxidative
stress increases and this balance is disrupted. The stability between ROS as signaling
molecules and a surplus of ROS contributing to oxidative stress depends on the reduction
potential of complexes of the mitochondrial ETC and the ability of antioxidant systems to
remove ROS [2][34].
It is estimated that under physiological conditions 2% of the oxygen consumed in aerobic
respiration is converted into ROS, specifically superoxide anion [3]. The primary enzymes
that function to convert harmful ROS to less harmful species are superoxide dismutase
(MnSOD and Cu/Zn SOD), glutathione peroxidase (GPx) and catalase (Figure 7) [2, 3,
25, 31].
In diabetic retinopathy, altered redox cycling has been correlated with excess ROS and
depleted antioxidant defense mechanisms [21]. Therefore, absence of antioxidants
directly contributes to ROS and oxidative stress in disease. Furthermore, during chronic
hyperglycemia excess generation of ROS overwhelms the antioxidant pathways resulting
in increased ROS and RNS formation and activation of oxidative stress pathways [21,
59].
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Figure 7: Intracellular antioxidant mechanisms. Mn-SOD and Cu/Zn-SOD convert
superoxide to hydrogen peroxide. Glutathione peroxidase and catalase further reduce
hydrogen peroxide to water and oxygen. Glutathione peroxidase uses a system to replenish
reduced glutathione as a substrate. O2-: superoxide; SOD: superoxide dismutase; H2O2:
hydrogen peroxide. Lazo-de-la-Vega-Monroy et al. 2013.

SOD is the first line of defense against superoxide. SOD is present in nearly all cells and
converts •O2 - into H2O2 (Figure 7). As the hydrogen peroxide may still react with other
ROS, degradation is necessary by either one of the other two antioxidant enzymes, GPx
or catalase [10, 12].
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GPx catalyzes the degradation of H2O2 by reduction, where two glutathione (GSH)
molecules are oxidized to glutathione disulfide (GSSG). Regeneration of GSH by GSHreductase, requires NADPH, which is oxidized to NADP+. Catalase, on the other hand, is
localized primarily in peroxisomes, and so it detoxifies the hydrogen peroxide that diffuses
from the mitochondria to the cytosol, converting it into water and molecular oxygen [10,
12].
Additionally, some nonenzymatic antioxidant mechanisms help regenerate GSSG back
into GSH. Antioxidant vitamins including A, C, E and alpha-lipoic acid are among these
mechanisms. Although all these antioxidant defenses work together to eliminate H2O2
(and thus superoxide) from the cell, in the presence of reduced transition metals (Cu, Fe),
H2O2 can be transformed into •OH, which is a highly reactive ROS, by the Fenton reaction
(Figure 7) [10, 23].
Glutathione
Reduced glutathione (GSH) is key antioxidant in Müller glial cells. The antioxidant
capacity of GSH is the greatest within the cell [2]. GSH is thought to be the main
contributor of redox regulation and has been suggested to be the primary ROS scavenger
[3]. In the presence of ROS, GSH is oxidized to oxidized glutathione (GSSG) via
glutathione peroxidase (GPx).
The redox pair, GSH/GSSG, is found in the cytoplasm and in the mitochondrial
intermembrane space and matrix [3]. Mitochondria contain about 15% of total cellular
GSH [2]. The ratio of GSH to GSSG within the cell is indicative of degree of oxidative
stress [2] where low ratios are indicative of oxidative stress. GSSG influences ROS
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accumulation within the mitochondria and promote the disruption of the mitochondrial
membrane potential [2]. In addition, ROS influence the formation of the mitochondrial
permeability transition pore by oxidizing GSH, causing its opening and the initiation of
apoptosis [2]. Thus, during DR, a decrease in the GSH/GSSG ratio contributes to excess
ROS and leads to oxidative stress, mitochondrial dysfunction, and disease.

There are multiple hypotheses as to why glutathione becomes depleted. One includes
increase in neurotransmitter production with the purpose of detoxifying the rest of the
retina [6]. This may outcompete for the precursors required for glutathione synthesis,
therefore decreasing the amount of GSH in the cell and may contribute abnormal redox
signaling and oxidative stress. Another hypothesis includes the modulation of GSH
through the effects of high glucose on intracellular transcription factors responsible for the
generation of antioxidants [50, 51]. One study found that high glucose affects the binding
capabilities of NF-E2-related factor 2 (Nrf2), a transcription factor responsible for
transcribing GSH [51]. When Nrf2 is bound, it cannot translocate into the nucleus to
transcribe GSH. Therefore, DR conditions may affect the transcription of GSH, resulting
in decreased antioxidant capacity, progression disease pathogenesis through increased
oxidative stress. Lastly, glutathione may be depleted due to the burden of excess
intracellular ROS. Reduced GSH may attempt to clear ROS but may be depleted more
rapidly than it is being produced; resulting in more ROS production.
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In a Müller cell model of DR, antioxidant levels are expected to decrease. However, levels
of GSH within the cell have been variable in many models involving retinal degeneration,
injury and disease [23]. Some studies report a decrease in GSH [19] as expected, while
others report an increase in GSH [3, 23] which could be associated with upregulation of
antioxidants to decrease oxidative stress.
As previously discussed, Müller cells exposed to hypoxic conditions for three days had
increased levels of ROS [34]. However, with the addition of the antioxidant, ebselen, ROS
levels decreased [34]. This suggests that the presence antioxidants may be enough to
decrease disease prevalence.

In high glucose conditions, Müller cells exposed to tert-butylhydroquinone, a chemical
that promotes oxidative stress, were found to increase GSH levels by 77% compared to
control cells after 12 hours [19], which is unexpected. However, in the same study, Müller
cells exposed to high glucose media for one week had decreased levels of GSH [19].
These observations suggest that under conditions of oxidative stress, GSH may be
initially upregulated to clear excess ROS. Yet after chronic oxidative stress, GSH may be
depleted resulting in more oxidative stress and disease progression.

Due to the variability of GSH concentrations in Müller cells, other components of the
glutathione mechanism maybe altered in disease as well. Müller cells exposed to hypoxic
conditions for three days had similar levels of GPx to those exposed to normal conditions
[34]. In the same hypoxic conditions, the addition of ebselen unexpectedly resulted in
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increased GPx levels. Additionally, GPx activity is upregulated when GSSG is increased
[2]. However, a deficiency in GPx was found to be accompanied by oxidative stress,
enhanced cell death, and increased angiogenic factors in the hypoxic retina [35]. This
study suggests that GPx may play a role in the variability of GSH levels in Müller cells in
high glucose conditions [34] and may be a compensatory mechanism for GSH redox
cycling. Therefore, the variability of GSH levels seen in Müller cell may closely related to
the regulation of the glutathione mechanism and the duration of hyperglycemic exposure.
Thus, GSH levels are particularly important in the Müller cells of DR patients.

Treatment of Diabetic Retinopathy (Diabetic Macular Edema)
The primary cause of vision loss in diabetic patients with diabetic retinopathy is diabetic
macular edema (DME). Alteration of the blood–retinal barrier (BRB) and inflammation
are hallmark features in the pathogenesis of DR and DME [8, 18, 41, 42, 47]. Inflammation
plays a crucial role with involvement of chemokines and cytokines including vascular
endothelial growth factor (VEGF). VEGF is a potent cytokine and vaso-permeability factor
that has been targeted in multiple, large clinical trials. Several anti-VEGF drugs are used
as first line therapy in the treatment of diabetic macular edema (DME). These drugs are
administered by injection in the vitreous humor on a monthly basis and have been shown
to be effective in vision improvement and prevention of vision loss, However, many DME
patients do not show complete response to anti-VEGF drugs despite multiple intravitreal
injections with these drugs. Also, the effect seems to be transient in those responders,
and many patients do not show complete resolution of fluid [30, 47, 61]. Other
interventions for DR include non-pharmacologic therapies (laser photocoagulation,
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viterectomy) and pharmacological therapies involving the intraocular injection of antiangiogenic agents or corticosteroids that target the excessive vascular growth and
inflammation, respectively [30, 41, 47]. All of the currently used intraocular interventions
are invasive, expensive and only partially effective. A novel non-invasive therapeutic
approach that targets retinal cell metabolism and inflammation directly would provide a
considerable improvement over current therapeutic approaches.

Photobiomodulation
Photobiomodulation (PBM) by light in the far-red to near-infrared (NIR) range of the
electromagnetic spectrum applied directly to damaged tissue, has been shown to act on
mitochondria-mediated signaling pathways to preserve mitochondrial function, attenuate
oxidative stress, stimulate the production of cytoprotective factors, preventing cell death
in in vitro and in vivo experimental models (Figure 8) [5, 16, 32]. PBM is a non-invasive,
inexpensive and effective treatment modality for diseases resulting in retinal injury [5, 11,
16]. Recent studies by Tang et al. have demonstrated the efficacy of 670 nm PBM in four
patients with macular edema. The long-term objective of our studies is to develop PBM
as a stand-alone or adjunct therapy for the treatment of DME and other retinal diseases.

23

Figure 8: Hypothesized Mechanism of Acton of Photobiomodulation. Far-red and Nearinfrared light target the mitochondria and activate the production cytoprotective molecules
to create a stable intracellular microenvironment. Cco: cytochrome c oxidase

Far-red and NIR PBM have been investigated in several models of retinal disease. PBM
has been shown to attenuate inflammation and oxidative stress and protect retinal
function in experimental and clinical studies [28, 36]. Studies have shown that 670 nm
light is absorbed by cytochrome-c-oxidase resulting in stimulation of mitochondrial
bioenergetic function and increased ATP synthesis (Figure 8) [5, 11, 16, 28].
Sivapathasuntharam et al. (2017) demonstrated the effects of 670 nm light therapy on
mitochondrial function in aging mice and found that increased retinal mitochondrial
function correlated with improved vision. Cytochrome c oxidase levels were increased
after 670 nm light exposure [32] compare to no light treatment. These findings suggest
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that 670 nm light improved mitochondrial and retinal function and may be advantageous
therapy for retinal disease.
Similarly, in cell culture and animal models of DR, 670 nm light therapy was beneficial
resulting in decreased ROS production [28, 36] and slowed disease progression [11, 14,
16]. In a rat model of DR, Tang et al. (2013) found that 670 nm light reduced retinal
ganglion cell death and improved retinal function. However, little is known about upstream
mechanisms in the Müller cell model of DR. Therefore, our objectives are to evaluate how
670 nm light modulates early mechanisms in DR.
SUMMARY AND GAP IN KNOWLEDGE
Mitochondrial dysfunction and oxidative stress are primary contributors to the
pathogenesis of diabetic retinopathy. Many studies have shown that that ROS increases
in response to high glucose conditions [8, 46]. Similarly, the mitochondria become
dysfunctional and antioxidants are depleted, furthering ROS production. ROS activates
NFκB leading to increased VEGF and DR pathogenesis [8, 15,18, 26, 42, 46].
Dysfunctional mitochondria have been shown to activate pathologic and apoptotic
signaling leading to decreased energy production and cell demise, potentiating DR
symptoms. Previous studies indicate that PBM therapy may be beneficial to treat DR
symptoms, however, the intracellular mechanisms that PBM modulates is not well
understood.
Previous studies show that PBM is beneficial in improving mitochondrial function and
decreasing oxidative stress, both by decreasing ROS and promoting antioxidant
mechanism. Further, NFκB has been found to be decreased after treatment with 670 nm
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light in Müller glial. These studies suggest that PBM may be beneficial in this pathogenic
pathway induced by diabetes.
The importance of Müller cells in retinal disease is becoming increasingly understood. As
retinal support cells, Müller cells are responsible for cell homeostasis and retinal
maintenance. Currently, few studies are studying the PBM mechanisms on mitochondrial
dysfunction, oxidative stress and glutathione status mitochondrial dysfunction on a DR
Müller cell model. Therefore, more studies are necessary to understand the importance
of Müller cell function and how light treatment modulate pathogenic signaling within the
cell. The following studies were performed to assess PBM mechanistic modifications early
in DR pathogenesis. We have chosen to examine various aspects of mitochondrial
dysfunction and simultaneous redox balance via ROS and glutathione status in Müller
glia.

HYPOTHESIS AND SPECIFIC AIMS
Diabetic retinopathy (DR) is the most common cause of visual impairment and blindness
in the United States [9]. As a result of diabetes mellitus, excess glucose in the blood
disrupts normal cellular mechanisms in the retina, leading to oxidative stress,
inflammation and neovascularization [8, 15, 46]. In DR, abnormal cellular signaling has
been suggested to be initiated by mitochondrial dysfunction and excess production of
reactive oxygen species (ROS) [8, 10]. Excess ROS results in the activation of
unregulated transcription of growth factors responsible for inflammation and
angiogenesis [4, 8, 10]. Consequently, current therapies aim to prevent blood vessel
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growth to avert the progression of DR by targeting the downstream molecule, vascular
endothelial growth factor, responsible for angiogenesis. While these treatments slow
disease progression, they are invasive, costly and can cause serious adverse effects
[30]. Photobiomodulation (PBM) is a noninvasive and unique therapeutic treatment,
which uses far-red to near-infrared light in the 630-1000 nm range of the light spectrum
[5]. PBM has been found to act by multiple mechanisms and has been studied in a
variety of animal and cellular models of retinal disease, including models of DR [5, 10,
11, 14, 16, 28]. In animal models of DR, PBM has been shown to attenuate inflammation
and enhance retinal function [5]. However, upstream mechanisms by which PBM is able
to decrease inflammation remain elusive. We hypothesize that 670nm PBM will
ameliorate mitochondrial dysfunction and improve redox status in a rat Müller cell model
of diabetic retinopathy.
Specific Aim 1) Determine the effects of 670 nm PBM on mitochondrial function in a
cultured Müller cell model of DR. Our working hypothesis is that treatment with 670nm
PBM will improve bioenergetics and increase ATP concentrations in Müller glial cells
exposed to increased glucose concentrations.
Specific Aim 2) Determine the effects of photobiomodulation on antioxidant status in a
cultured Müller cell model of DR. Our working hypothesis is that treatment with 670nm
PBM will attenuate ROS production and increase intracellular concentrations of the
reduced form of the antioxidant, glutathione, in Müller glial cells exposed to increased
glucose concentrations.
Our goal is to better understand how PBM modulates disease and characterize this
treatment paradigm as a potential early intervention to prevent DR progression.
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Figure 9: Proposed timeline for Müller glial cells in high glucose conditions. Previous
studies in our lab show that NFKB, ICAM and VEGF are modulated after 3 days or 72 hours
in high glucose conditions. However, upstream mechanisms have yet to be elucidated. ROS:
reactive oxygen species; GSH: reduced glutathione; GSSG: oxidized glutathione; NFKB:
Nuclear Factor K beta; VEGF: vascular endothelial growth factor; ICAM: Intracellular
adhesion molecule; AGEs: advanced glycosylated end products; PKC: protein kinase c; AII:
angiotensin II

MATERIALS AND METHODS
Cell Line: Experiments were performed on rat Müller glial cells. Müller cells span 70% of
the retina providing structural and metabolic support [4]. Müller cells have recently been
shown to be a target for DR therapy due to their secretion of high levels of VEGF in DR
conditions [8, 10, 46]. Previous studies have shown that Müller cells upregulate NFKB
activity in 3 days under diabetic conditions [Fisher, 2015], thus making them an
appropriate target for PBM. Müller cells were obtained from John Mieyal, Case Western
Reserve University. Müller cells were exposed to high glucose (25mM) or normal glucose
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(5mM) Dulbecco’s modified Eagle’s medium (Invitrogen 11995 and Invitrogen 11885,
respectively) to mimic hyperglycemic and normal conditions. Cell medium was changed
daily to maintain constant glucose load. Müller cells were grown in a phenol free DMEM
normal (5mM) or high glucose media (25mM). Phenol free normal glucose media
(Invitrogen 11054-020) was supplemented with 5% L-glutamine and high glucose phenol
free media (Invitrogen 21063-029) was supplement with 110mg/L sodium pyruvate to
sustain Müller cell growth in culture.
Light Treatment: Cell cultures were exposed to 670 nm light from a light emitting diode
(LED) array (10 cm x 25 cm) (Quantum Devices Inc. Barneveld, WI) positioned on top of
the culture plate. Light treatment consisted of 670 nm irradiation at an irradiance of 25
mW/cm2 for 180 seconds resulting in a radiant exposure or dose of 4.5 J/cm2 [dose
calculation: irradiance (W) x exposure time (sec) = radiant exposure J/cm2 0.025 W/cm2
x 180 sec = 4.5 J/cm2]. Cells grown in normal glucose (5 mM) or high glucose (25 mM)
medium were treated with 670nm light one time at 24 hours. Sham-treated cells were
handled in a similar manner except that the LED array was not illuminated. All assays
were conducted one hour following PBM-treatment. Studies in the Eells laboratory have
demonstrated NFκB activity and transcriptional changes after three days in
hyperglycemic conditions [Fischer, 2015]. We reasoned that high-glucose mediated
mitochondrial dysfunction and oxidative stress were early events in this in vitro model of
diabetic retinopathy. Therefore we examined the effects of high-glucose exposure and
PBM after 24 hours in culture.
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Table 1: Summary of treatment groups

Figure 10: Summary of Müller cell protocol. Müller cells were plated at 30,000 cells per
well in a 96 well plate, exposed to either 5mM or 25mM glucose conditions. After 23 hours,
media was changed, and cells incubated for another hour. Müller cells were treated with
670 nm light for 180 seconds and allowed to incubate for one hour. Cells were harvested
and assayed per individual protocol.

Assessment of metabolic activity as a measure of mitochondrial function
The

MTT

(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium

bromide)

assay

assesses metabolic activity indirectly by measuring the reduction of yellow tetrazolium
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salt. MTT contains lipophilic side groups and is thus able to pass the cell membrane
where it is reduced in viable cells by mitochondrial or cell plasma enzymes including
oxidoreductases, dehydrogenases, oxidases, and peroxidases using NADH, NADPH,
succinate, or pyruvate as electron donor. This results in a conversion of MTT to the waterinsoluble formazan which has a purple color.
Retinal Müller glial cells were plated in triplicate in two 96 well plates at a density of
30,000 cells/well in normal or high glucose conditions for 24 hours. At 24 hours, respective
media were exchanged and incubated for one hour. One plate was treated with 670 nm
for 180 seconds. After one hour, media was removed, and cells were washed with 1x
PBS. Then 100 µL of MTT and medium solution (5mg/mL MTT) was incubated for 3 hours
at 37 ⁰C. The MTT solution was exchanged with an MTT solvent (10%Triton x100 and
isopropanol with 0.1N HCl (final concentration) and was shaken for 15 mins in the dark.
The MTT solvent was pipetted several times through the shaking process to allow proper
cell lysis in sample wells. Absorbance was read at 590 nm.

Determination of mitochondrial membrane potential as a measure of
mitochondrial function
Mitochondrial membrane potential (ΔΨm) was measured as a parameter of
mitochondrial function in DR conditions using the TMRE Mitochondrial Membrane
Potential Assay Kit (Abcam, Cambridge, MA) Tetramethylrhodamine ethyl ester (TMRE)
is a positively charged molecule that permeates cells and accumulates in metabolically
active mitochondria due to the highly negative membrane potential across the outer
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mitochondrial membrane. Mitochondrial dysfunction is characterized by a reduction in
the ΔΨm and is measured as a reduction in TMRE staining.
Müller glial cells were plated in triplicate in 96 well plates at a density of 30,000 cells/well
in normal or high glucose conditions for 24 hours. At 24 hours, respective media were
exchanged and incubated for one hour. One plate was treated with 670 nm for 180
seconds at an intensity of 4.5 J/cm2. After one hour, media was removed, and cells were
washed with 1x PBS. A 200 nM TMRE solution was in respective glucose medium
prepared from 1mM TMRE stock; 100 uL solution was added per well and incubated for
30 mins. The TMRE solution was removed and cells were washed with then read in 100uL
PBS/0.2% BSA solution. Fluorescence was read via plate reader with EX/EM: 549/575
nm. FCCP (carbonyl cyaninde 4-(trifluoromethoxy) phenylhydrazone) at a concentration
of 20uM was prepared from 50mM FCCP stock solution as a positive control. FCCP is an
ionophore uncoupler of oxidative phosphorylation and destroys mitochondrial membrane
integrity, disrupting membrane potential.

Assessment of intracellular ATP concentrations as a measure of mitochondrial
function
We utilized ATP concentrations were measured as an additional index of mitochondrial
bioenergetic function. ATP concentrations were determined using Promega CellTiter-Glo
2.0 Assay (Promega Inc., Madison, WI). Concentrations of phosphorylated adenosine
nucleotides, including the universal energy carrier adenosine 5′-triphosphate (ATP) and
its metabolites adenosine 5′-diphosphate (ADP) and adenosine 5′-monophosphate
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(AMP), define the energy state in living cells and are primarily dependent on mitochondrial
function. ATP is the energy exchange factor that connects anabolism and catabolism. It
is required for major reactions and processes that occur in living cells, including muscle
contraction, phosphorylation and active transport. Luminescence provides a simple and
effective tool for measuring ATP concentrations. This Promega ATP detection assay
uses firefly luciferase to convert ATP and luciferin to oxyluciferin and light. The light
emitted in this reaction is directly proportional to the concentration of ATP present. Using
the ATP detection standard, quantitative measurement of cellular ATP content can be
achieved with a dynamic range of 12 fmol to 10 pmole of ATP.
Müller glial cells were plated in triplicate in 96 well opaque-walled plates at a density of
30,000 cells/well in phenol free normal or high glucose conditions for 24 hours. At 24
hours, respective medias were exchanged and incubated for one hour. One plate was
treated with 670 nm light for 180 seconds at an intensity of 4.5 J/cm2. After 30 mins, plates
were removed from 37 ⁰C and incubated at room temperature for another 30 mins. Then
an equal volume of CellTiter-Glo 2.0 Reagent (100uL) was added to Müller cells in their
respective media (100uL). Plates were shaken for 2 mins to induce cell lysis and
incubated at room temperature for 10 mins to establish the correct temperature gradient.
Luminescence was recorded at a gain from 100-120. Sample values were compared to
an ATP standard curve.
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Assessment of ROS concentration in Müller cells
Intracellular production of ROS in the form of hydrogen peroxide (H2O2) was measured
using the dichlorodihydrofluorescein diacetate (DCF-DA) method (Cayman Chemical
Inc., Ann Arbor, MI) [44]. The DCF assay is a fluorescence assay that measures the
concentration of hydrogen peroxide in the cell. This is done with the addition of a DCFDA dye that fluoresces when oxidized into DCF by ROS (H2O2). Fluorescence was
measured using a BioTek plate reader (BioTek, Inc., Winooski, VT) at an excitation
wavelength of 475 nm and emission wavelength of 529nm.
Müller glial cells were plated in triplicate in 96 well plates at a density of 30,000 cells/well
in normal or high glucose conditions for 24 hours. At 24 hours, respective medias were
exchanged and incubated for one hour. One plate was treated with 670 nm for 180
seconds at an intensity of 4.5J/cm2. Cells were washed with 1x PBS and a 40 uM DCFDA
solution (in respective media) was overlaid immediately. DCFDA solution was allowed to
incubate for 1 hour. After 1 hour, DCFDA solution was removed and replaced with 100uL
of a 1x buffer and read via fluorescence in a plate reader with EX/EM 484nm/528 nm with
a gain of 100-120. A positive control of TBHP (tertbutyl hydrogen peroxide) (inducer of
ROS production) was utilized to confirm assay results.
Measure of glutathione status in Müller cells
Glutathione (GSH) is an essential intracellular antioxidant. GSH and is thought to be the
main contributor of intracellular redox regulation and a key ROS scavenger [3].
Intracellular concentrations of this critical antioxidant, glutathione were assessed using
an enzyme recycling assay (Cayman Chemical Inc., Ann Arbor, MI). The GSH assay
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employs the enzymatic recycling of the glutathione to quantify levels of GSH via
glutathione reductase. DTNB (5,5'-dithio-bis-2-nitrobenzoic acid) reacts with the
sulfhydryl group of GSH and produces the molecule TNB (5-thio-2-nitrobenzoic acid),
producing a yellow color. The new molecule GSTNB is then reduced by glutathione
reductase to again produce GSH and TNB. In this process, the rate of TNB production is
proportional to the rate of the glutathione mechanism and concentration of GSH in our
sample. The TNB molecule was measured at the absorbance of 405 nm. Utilizing the
glutathione mechanism in this assay allows the measurement of both reduced and
oxidized glutathione to reflect total glutathione in a ratio. The GSH assay was used to
assess antioxidant status to quantify the ratio of reduced to oxidized glutathione in Müller
cells after treatment with glucose and light, as described above. This colorimetric assay
was performed on the four groups of cells and compared to standard curve. Cellular
proteins will be precipitated out prior to analysis to ensure measurement of only
glutathione.
Müller glial cells were plated in 6-well plates at a density of 1,000,000 cells/well in normal
or high glucose conditions for 24 hours. At 24 hours, respective media were exchanged
and incubated for one hour. One plate was treated with 670 nm for 180 seconds at an
intensity of 4.5J/cm2. After one hour, media was removed, and cells were washed with 1x
PBS. Müller cells were scraped, collected and centrifuged for 10 min at 1000xg at 4 ⁰C.
Cell pellet was homogenized in 400uL of cold buffer (50mM phosphate buffer pH6-7
containing 1mM EDTA). Samples were sonicated on ice with an amplitude setting of 40%
for 20 seconds, twice to lyse cells. Samples were then centrifuged at 10,000xg for 15
mins at 4 ⁰C. The supernatant was deproteinated by adding 40uL of 10% W/V MPA
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(metaphosphoric acid) to the sample and vortexed. Samples were incubated at room
temperature for 5 mins and centrifuged at 2000xg for another 5 mins. After the
supernatant was removed, 50uL of 4M TEAM (triethanolamine) reagent was added to
each sample and vortexed. Half of each sample was removed and added to a new tube
to assess both total glutathione and oxidized glutathione separately. A 1M 2-vinylpyridine
(10.8uL 2-VP, 89.2uL of 100% ethanol) reagent was prepared and 10uL was added per
1 mL of sample. Samples with 2-VP measure oxidized glutathione. Incubated 2-VP
samples at room temperature for 60 mins, while samples that do not contain 2-VP will
incubate on ice for 60 mins. The assay cocktail (MES buffer, co-factor mixture, enzyme
mixture, DI water and DTNB) was added to a 96 well plate with 150 uL/well. Then 50uL
of sample was added to each well. The plate was covered and was shaken in the dark
for 25 mins and read at an absorbance of 405 nm. A reduced glutathione (GSH) and
oxidized glutathione (GSSG) standard curve was prepared. Buthionine sulfoximine (BSO)
was used as a positive control where 0.1 mM was placed in cellular media for 20 hours
to deplete glutathione levels to show our assay can measure changes in cellular GSH.

Determination of GPx activity
Glutathione peroxidase (GPx) activity will also be measured (Cayman Chemical
Glutathione Peroxidase Assay). Previous studies indicate that a defect in GPx activity
could result in oxidative stress and progression of DR [35]. Therefore, this assay was
used to measure GPx activity in Müller cells after treatment with glucose and light. This
assay measures GPx activity indirectly via the glutathione redox coupled reaction. After
GPx catalyzes GSH to GSSG, it is recycled back to GSH by glutathione reductase and
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oxidation of the cofactor, NADPH to NADP+. The oxidation of NADPH to NADP+ is
measured at an absorbance of 340 nm and is related to GPx activities in the cell.
Determining GPx activity describes the rate of GSH oxidization to GSSG in the presence
of ROS where an increased rate is suggestive of oxidative stress. This colorimetric assay
will be performed on the four treatment groups.
Müller glial cells were plated in 6 well plates at a density of 1,000,000 cells/well in
normal or high glucose conditions for 24 hours. At 24 hours, respective medias were
exchanged and incubated for one hour. One plate was treated with 670 nm for 180
seconds at an intensity of 4.5J/cm2. After one hour, media was removed, and cells were
washed with 1x PBS. Cells were scraped and centrifuged for 10 mins at 2000xg at 4 ⁰C.
Sample pellets were homogenized in 400uL of cold buffer (50mM phosphate buffer
pH6-7 containing 1mM EDTA) and centrifuged at 4 ⁰C for 15 mins at 10,000xg. After the
supernatant was collected 20uL of samples were added to a 96 well plate. An assay
cocktail (Assay buffer, Co-substrate, NADPH) was added at a volume of 170uL total per
well. Quickly before reading, 20uL of cumene hydroperoxide was added and shaken for
several seconds. Absorbance was read kinetically every minute for 5 mins. A positive
control of glutathione peroxidase was utilized. Data was collected as a function of
absorbance per minute. GPx activity was determined by using the NADPH extinction
coefficient of 0.00373 uM-1. One unit is defined as the amount of enzyme that will
oxidize of 1.0 nmol of NADPH to NADP+ per minute at 25 C. GPx activity = (absorbance
per min/0.00373 uM-1) x (0.19 mL/0.02 mL) = nmol/min/mL.
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Statistical Analysis: Samples were measured in duplicate or triplicate. All glucose and
light conditions were normalized to the normal glucose sham condition. Averages,
standard deviations and standard errors were calculated. Differences between each
sample group were analyzed by ANOVA, followed by Bonferroni post-hoc testing. The
alpha for statistical analysis was set at a p value of 0.05.

Results
Specific Aim 1: Determine the effects of 670 nm PBM on mitochondrial function in a
cultured Müller cell model of DR. Our working hypothesis is that treatment with 670nm
PBM will improve mitochondrial function in Müller glial cells exposed to increased glucose
concentrations.
Rationale: Retinal Müller glial cells are susceptible to hyperglycemia-induced injury
leading to ROS production and NFKB modulation via multiple pathways [8, 18]. An early
event in the pathology of diabetic retinopathy is the disruption of mitochondrial function
leading to downstream signaling culminating in disease. Previous studies in the Eells’
laboratory have shown that NFκB activity increases in Müller cells after exposure to high
glucose media for 3 days [Fisher, 2015]. Treatment with 670 nm light decreases NFKB
activity after 3 days of high glucose exposure, suggesting prevention of DR progression
[Fisher, 2015]. Current treatments aim to block VEGF. However, these changes are seen
late in disease pathogenesis and, early mechanisms of disease remain to be elucidated.
Investigations into the mechanisms of PBM have shown that FR/NIR photons are
absorbed by the mitochondrial photoacceptor molecule, cytochrome c oxidase, triggering
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intracellular signaling pathways that culminate in improved mitochondrial energy
metabolism, increased cytoprotective factor production, and cell survival [5, 11, 16, 28,
32]. Studies in cultured retinal ganglion cells (RGC5), RPE (ARPE 19) and photoreceptors
(661W) have shown that 4 days of exposure to elevated glucose concentrations
increased superoxide production, inflammatory biomarker expression, and cell death. 670

nm light (5 J/cm2) administered 2 times per day for 4 days inhibited all of these
abnormalities. The studies in our lab have focused specifically on Müller glial cells and
investigated the effect of 24 hours of elevated glucose exposure and a single treatment
with 670 nm light. We assessed mitochondrial function by measuring metabolic activity,
mitochondrial membrane potential and the intracellular concentration of ATP. Because
NFKB activity is modulated after 3 days of high glucose exposure, we propose that
mitochondrial dysfunction will occur earlier in the disease pathway. Müller cells were
exposed to high glucose for 24 hours before treating with 670 nm light and assessment
for metabolic bioenergetics. Mitochondrial function was indirectly measured utilizing the
MTT assay, TMRE assay, and intracellular concentration of ATP to determine metabolic
activity, mitochondrial membrane potential and oxidative phosphorylation as key
components of mitochondrial function.
Effects of photobiomodulation on mitochondrial function in a Müller retinal glial
cells
A. 670 nm PBM Restores NAPDH-Dependent Oxidoreductase Activity in Müller Glial Cells
Under High Glucose Conditions.

The MTT assay is a colorimetric assay for measuring cell metabolic activity. It is based
on the ability of nicotinamide adenine dinucleotide phosphate (NADPH)-dependent
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cellular oxidoreductase enzymes to reduce the tetrazolium dye, 3-[4,5-dimethylthiazole2-yl]-2,5-diphenyltetrazolium bromide (MTT) to its insoluble formazan, which has a purple
color. The MTT assay is dependent on mitochondrial respiration and indirectly serves to
assess the cellular energy capacity of a cell.
Müller cell NADPH-dependent oxidoreductase activity was reduced by nearly 50%
following 24 hours in high glucose medium (n=3, p<0.01), indicative of a reduction in
mitochondrial respiration and cellular energy capacity. A single treatment with 670 nm
light (dose 4.5 J/cm2) increased NADPH-dependent oxidoreductase activity by 60% from
high glucose conditions, to values similar to those measured in cells cultured in normal
glucose concentrations. However, this increase was not significant.
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Figure 11: 670 nm PBM Restores NAPDH-Dependent Oxidoreductase Activity in Müller Glial
Cells under High Glucose Conditions. Müller Glial cells were cultured in either normal glucose
or high glucose medium for 24 hours. 670nm or sham control was applied to the cells at 4.5
J/cm2. All assays were normalized to the normal glucose sham levels. NAPDH-dependent
oxidoreductase activity was analyzed using MTT, n=3. ** p<0.01.

B. 670 nm PBM Restores Mitochondrial Membrane Potential in Müller Glial Cells
Under High Glucose Conditions.
Mitochondrial membrane potential is the driving force for electron transport essential for
the maintenance of mitochondrial membrane integrity [17, 25]. As the membrane potential
drops, the ETC slows, resulting in decreased ATP production and increased ROS
generation. A loss of integrity causes disrupted morphology and function and the
activation of apoptotic signaling leading to severe DR. Mitochondrial membrane potential
was assessed indirectly via TMRE assay to determine one aspect of mitochondrial
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function. As mitochondrial membrane potential is lost, TMRE values will decrease. In our
study, Müller cells were cultured in either normal or high glucose conditions for 24 hours
and treated with or without 670 nm light. Müller cells in high glucose conditions showed
significantly disrupted mitochondrial membrane potential, shown by a 50% decrease in
TMRE values, compared to the normal glucose sham (n=3, p<0.0001), suggesting
decreased mitochondrial function in diabetic conditions after 24 hours.
Müller cells in high glucose conditions for 24 hours and treated with 670 nm light showed
significantly increased TMRE values compared to the high glucose sham group (n=3,
p<0.0001). This increase shows the restoration of mitochondrial membrane potential in
addition to improved mitochondrial function, indirectly. At the same time, the high glucose
670 nm light-treated Müller cells showed no significant difference from the normal glucose
sham group (n=3).
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Figure 12: 670 nm PBM Restores Mitochondrial Membrane Potential in Müller
Glial Cells Under High Glucose Conditions. Müller Glial cells were cultured in
either normal glucose or high glucose medium for 24 hours. 670nm or sham control
was applied to the cells at 4.5 J/cm2. All assays were normalized to the normal
glucose sham levels. Mitochondrial membrane potential was analyzed using TMRE.
n=3, done in triplicate. * p<0.05, ** p<0.01, **** p<0.0001.

C. 670 nm PBM Restores ATP concentrations in Müller Glial Cells Under High
Glucose Conditions.
Another key biomarker of mitochondrial bioenergetics is ATP production. Müller cells
require an abundant amount of energy to support other cells in the retina and to maintain
homeostasis. Over time, hyperglycemic conditions induce mitochondrial dysfunction
resulting in increased ROS production and decreased ATP synthesis. Müller cells were
exposed to normal or high glucose conditions for 24 hours and intracellular ATP
concentrations were determined using a sensitive luminescence-based assay. In high
glucose conditions, ATP concentrations were decreased compared to the normal glucose
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sham conditions, as expected (n=2). After 24 hours and treatment with 670 nm, Müller
cells in high glucose media showed increased ATP concentrations similar to cells grown
in normal medium (n=2, p=0.089).
As expected, ATP concentrations in Müller cells cultured in normal glucose
concentrations and treated with 670 nm light did were not different from normal glucose
controls (n=2).

P= 0.089

Figure 13: 670 nm PBM Restores ATP Concentrations in Müller Glial Cells
Under High Glucose Conditions. Müller Glial cells were cultured in either normal
glucose or high glucose medium for 24 hours. 670nm or sham control was applied
to the cells at 4.5 J/cm2. All assays were normalized to the normal glucose sham
levels. ATP concentrations were analyzed using CellTiter-Glo (Promega) assay,
n=2), performed in duplicate.
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Effects of Photobiomodulation on Antioxidant Status in a Müller cell model
Specific Aim 2) Determine the effects of photobiomodulation on antioxidant status in a
cultured Müller cell model of DR. Our working hypothesis is that treatment with 670nm
PBM will attenuate ROS production and increase intracellular concentrations of the
reduced form of the antioxidant, glutathione, in Müller glial cells exposed to increased
glucose concentrations.
Rationale: The retina has a high need for antioxidant protection due to constant light
exposure, high oxygen consumption by photoreceptor cells and high concentrations of
polyunsaturated fatty acids in the outer segments [48] In addition, the outer retina
experiences circadian periods of hypoxia (dark) and hyperoxia (light) that add to retinal
oxidative stress [48]. Müller glial cells produce the key antioxidant, glutathione.
Glutathione is primarily responsible for maintenance of redox balance in the retina [2,3].
Glutathione status is generally expressed as the ratio of reduced GSH to oxidized
glutathione (GSSG). An increased GSH:GSSG ratio reflects greater concentrations of
reduced GSH than oxidized GSSG indicative of an abundance of reducing power. Under
hyperglycemic conditions, mitochondrial stress and DR-related signaling produce
significant amounts of ROS, leading to oxidative stress in Müller cells. Under physiological
conditions, Müller cells have abundant concentrations of reduced glutathione (GSH) to
detoxify excess ROS that is produced. GSH is utilized as a substrate in a redox
mechanism that reduces hydrogen peroxide into water via glutathione peroxidase (GPx).
In this process oxidized glutathione (GSSG) is formed. This reaction is coupled when
GSSG is further reduced by glutathione reductase (GR) back to GSH. The ratio of
intracellular GSH/GSSG is indicative of levels of oxidative stress present within the cell
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[2]. Antioxidant concentrations of GSH are significantly depleted in the diabetic retina due
the overburden of ROS surplus. Thus, during DR, a decrease in the GSH/GSSG ratio
contributes to excess ROS and leads to oxidative stress and disease progression.
Previous studies have indicated that GPx activity is modulated in hyperglycemic
conditions leading to dysregulated redox signaling and oxidative stress [35]. Similarly,
studies indicated that retinal cells exposed to high glucose conditions had depleted
intracellular antioxidant levels. However, 670 nm light treatment was found to increase
antioxidant levels within these cells [10]. Because the glutathione mechanism is the main
contributor to redox regulation, we measured ROS and glutathione levels in Müller cells.
To measure ROS, we used the Abcam DCFDA assay. To measure components of the
glutathione redox mechanism, used the Cayman Glutathione Assay to measure the
GSH/GSSG ratio and the Cayman Glutathione Peroxidase activity (GPx) assay to
measure redox enzyme activity.
D. 670 nm PBM decreases ROS production in Müller glial cells under high glucose
conditions
Oxidative stress is a common and significant factor in DR. Increasing intracellular ROS
activates NFκB and other pathogenic mechanisms leading to diabetic retinopathy.
Therefore, ROS is expected to increase early in disease.
PBM has been shown to attenuate oxidative stress in many disease models, including
DR [5, 11, 16, 28, 36, 38]. The majority of these studies have investigated the effects of
670 nm PBM on oxidative stress and ROS production several days after exposure to
cytotoxic stressors including high glucose. Ours is the first study to test the effects of a
single treatment with 670 nm PBM in light for 180 seconds 24 hours after exposure in
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their respective glucose conditions. Müller glial cells acutely exposed to high glucose
conditions.
Müller cells exposed to high glucose produced a 50% greater concentrations of ROS
(measured as H2O2 by this assay) than those cultured under normal glucose sham
conditions (n=3, p<0.001). Müller cells in high glucose and treated with 670 nm light
exhibited significantly decreased ROS concentrations to concentrations similar to thos
measured under normal glucose conditions.) (n=3, p<0.0001). Müller cells exposed to
normal glucose conditions were not anticipated to be modulated by PBM due to lack of
stress applied. As expected, 670 nm light did not affect the amount of ROS generated
intracellularly (n=3).
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Figure 14: 670 nm PBM Attenuates ROS Production in Müller Glial Cells Under High
Glucose Conditions. Müller cells were cultured in either normal glucose or high glucose
medium for 24 hours. 670nm or sham control was applied to the cells at 4.5 J/cm2.
Oxidative stress was analyzed using DCF-DA. *** p<0.001, **** p<0.0001. n=3, done in
triplicate

E. Glutathione concentrations in Müller glial cells
Total glutathione, reduced glutathione (GSH) and oxidized glutathione (GSSG)
concentrations were determined using a sensitive enzyme recycling assay (Cayman
Chemical, Ann Arbor, MI) first reported by Tietze [60]. In this assay, GSH is oxidized by
5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) resulting in the formation of GSSG and 5-thio2-nitrobenzoic acid (TNB). GSSG is then reduced to GSH by glutathione reductase (GR)
using reducing equivalent provided by NADPH. The rate of TNB formation is proportional
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to the sum of GSH and GSSG present in the sample and is determined by measuring the
formation of TNB at 414 nm.
We experienced difficulty in obtaining reproducible results using this assay. Table 2
shows the results from 3 experiments. The extreme range of total GSH from 3-13 µM
between experiments made it impossible to reliably determine the GSH/GSSG ratio.
Muller Glial Cell Glutathione Analysis
Assay #1
Treatment
NG Sham
NG PBM
HG Sham
HG PBM
Assay #2
Treatment
NG Sham
NG PBM
HG Sham
HG PBM
Assay #3
Treatment
NG Sham
NG PBM
HG Sham
HG PBM

Total GSH
mM
9.64
6.24
7.19
8.57

GSSG
mM
1.92
1.24
0.91
1.79

GSH
mM
7.72
4.99
6.28
6.78

GSH/GSSG
mM
4.01
4.03
6.85
3.78

Total GSH
mM
2.89
3.59
9.77
11.22

GSSG
mM
0.75
1.23
1.66
3.87

GSH
mM
2.14
2.35
8.11
7.34

GSH/GSSG
mM
2.85
1.9
4.87
1.89

Total GSH
mM
11.43
10.01
7.43

GSSG
mM
1.21
0.77
0.38

GSH
mM
10.22
9.23
7.05

GSH/GSSG
mM
8.43
11.82
18.66

13.4

0.85

12.54

14.58

GSH/Total
80%

100%
64%
81%
87%

74%

100%
109%
370%
342%

89%

100%
90%
68%

Table 2: Analysis of Glutathione Concentrations in retinal Müller glial cells
F. Glutathione Peroxidase Activity in retinal Müller cells
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GSH %
Control

122%

The conversion of GSH to GSSG is dependent on the activity of GPx. The activity of this
enzyme determines how quickly this reaction will occur. GSSG is recycled to GSH by
glutathione reductase and NADPH as a cofactor. This is a kinetic assay, where GPx is
the rate limiting step and NADPH to NADP+ is absorbed at 340nm, directly measuring
GPx activity.
We observed difficulties in the analysis of GPx activity. In our samples, GPx activity did
not differ from the background controls (Background:0.0158, Normal Glucose Sham:
0.0131, Normal Glucose PBM:0.0131, High Glucose Sham:0.0139, High Glucose
PBM:0.0135). We plated various densities of cells per plate ending with the same result.
A positive control using glutathione peroxidase was used to assess the validity of the
assay.
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Table 3: Analysis of Glutathione Peroxidase Activity in retinal Müller cells

DISCUSSION
The objective of the present study was to test the hypothesis that treatment with 670 nm
PBM will improve mitochondrial function and attenuate oxidative stress in an established
in vitro model of diabetic retinopathy. Our studies showed for first time that as little as 24
hours of exposure to high glucose is enough to disrupt mitochondrial function and
increase ROS production in Müller glial cells. We also showed for the first time that a
single treatment with 670 nm light attenuates the cytotoxic actions of high glucose
exposure within one hour. We conclude that this in vitro model of diabetic retinopathy
has considerable potential for use in the development and testing of therapeutic agents
to treat diabetic retinopathy. Our model can assess disruptions in metabolic activity
beginning with ROS generation and mitochondrial redox changes and culminating in
increased production of angiogenic and inflammatory mediators that are characteristics
of diabetic retinopathy.

A. Comparison of our investigations in the retinal Müller glial cell model of diabetic
retinopathy with those in the literature.
A number of studies have examined the effects of high glucose and other cell stressors
including hydrogen peroxide and hypoxia on mitochondrial function and redox balance in
cultured cells. Table 3 compares our findings to those of other studies in retinal Müller
glial cells and in other cell types.
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REFERENCE
Alex Hall
Thesis

MODEL
Rat Müller
glial cell line
(rMC1)

INSULT
5mM glucose
25mM glucose
24 hours

TREATMENT
670 nm PBM
(4.5 J/cm2)
180 sec treatment
Assays 1-hour
post PBM

[36] Tang et
al. 2013

RESULTS
Decreased
mitochondrial
metabolic activity
Decreased ΔΨm
Decreased ATP
Increased H2O2
Increased
GSH/GSSG
Increased superoxide
Increased oxidative
stress
Increased cell death

PBM EFFECTS
Increased
mitochondrial
metabolic activity
Restored ΔΨm
Increased ATP
Decreased H2O2
Decreased GSH/GSSG

Decreased ΔΨm
Decreased ATP

Increased ΔΨm
Increased ATP

NA

Rat Müller
glial cell line
(rMC1)
RGC(RGC5)
PR (661W)
RPE(ARPE19)
Fibroblasts

5mM glucose
30mM glucose
7 days

670 nm PBM
(10 J/cm2)
2x/day-4days

Hypoxia and
acidosis
4 and 5 days

[10] Devi et al.
2017

Rat Müller
glial cell line
(rMC1)

5.5 mM glucose
25 mM glucose
2 hours to 5 days

633 nm PBM
(5 J/cm2)
1 and 4 days
Assays 1 & 24
hours post PBM
None

[37] Tien et al.

Rat Müller
glial cell line
(rMC1)

5mM Glucose
30mM Glucose
4 days

None

[19] Lu et al.
1999

Rat Müller
glial cell line
(rMC1)
Rat Müller
glial cell line
(rMC1)
Human
Müller cell
line
(MIO-M1)
Primary
Human
Müller cells
(HuPMC)

TBH
12 hours

None

Decreased ΔΨm
Increased Superoxide
Increased H2O2
Decreased ATP
Increased mitophagy
Decreased ΔΨm
Decreased oxphos &
glycolysis
Increased mito
fragmentation
Increased apoptosis
Increased GSH 77%

5.5 mM glucose
28mM glucose
1 week
100µM hydrogen
peroxide
4 hours

None

Decreased GSH 30%

NA

None

Decreased ΔΨm
Increased H2O2
Decreased
NADPH/NADP
Increased HSP60
Decreased GSH

NA

[53] Zungu et
al. 2019

[19] Lu et al.
1999
[57] Zhang et
al. 2018

Decreased superoxide
Decreased oxidative
stress
Decreased cell death

NA

NA

Table 4. Effect of high-glucose and other stressors on mitochondrial function and redox
status in cultured cells with or without PBM.
Tien et al (2017) conducted a comprehensive investigation of the effects of hyperglycemia
on retinal Müller cell function. The purpose of their study was to determine if Müller glial
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cell loss reported in diabetic retinopathy [48] is attributable to mitochondrial dysfunction
by investigating the effects of high glucose on mitochondrial morphology; mitochondrial
membrane potential, cellular bioenergetics and cytochrome c release. For these studies
rat Müller glial cells (rMC-1) were grown in normal or high glucose medium for 7 days.
Their studies showed that cells grown in high glucose for 7 days exhibited significantly
increased mitochondrial fragmentation compared to those grown in normal glucose
medium.

Mitochondrial

membrane

potential

was

altered

and

both

oxidative

phosphorylation and glycolysis were inhibited under 7 days of high glucose conditions.
Cells exposed to high glucose also exhibited a significant increase in cytochrome c
release and apoptosis. The authors concluded that high glucose-induced mitochondrial
morphology changes and subsequent mitochondrial dysfunction may contribute to retinal
Müller cell loss associated with diabetic retinopathy [37].
Our data are among the first to show that an acute exposure (24 hours or less) to high
glucose conditions induces oxidative stress and mitochondrial dysfunction. We measured
a 50% increase in hydrogen peroxide generation in high glucose conditions. Our data
further show that mitochondrial metabolic activity (mitochondrial oxidoreductase activity)
was decreased by 40% and mitochondrial membrane potential was decreased by 50% in
high glucose conditions after 24 hours compared to normal glucose conditions, indicating
that

oxidative stress and disrupted mitochondrial function are early responses to

hyperglycemic conditions. Similarly, Zhang et al. (2018) showed that a mild oxidative
stress (100 µM hydrogen peroxide) produced an increase in ROS generation, a 30%
reduction in mitochondrial metabolic activity and a 20% reduction in mitochondrial
membrane potential within 6 hours in primary cultures of human Müller cells and a human
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cell line (MIO-M1) [57]. Thus, acute exposure to either high glucose or to oxidative stress
increases ROS generation and disrupts mitochondrial function.
We further showed that ATP concentrations were reduced nearly 40% by exposure to
high glucose. These findings are not statistically significant and preliminary at this time.
It will be necessary to repeat the ATP assay in future studies to confirm these
observations.
Under normal conditions the proton pumping activity of complexes I, III and IV of the
electron transport chain generate the mitochondrial membrane potential. Together with
the proton gradient, mitochondrial membrane potential forms the transmembrane
potential of hydrogen ions which is harnessed to make ATP [3, 42, 47]. Disruption of the
mitochondrial membrane results in a dysregulated proton gradient affecting electron
transport and increasing ROS production via ETC complexes. Few studies demonstrate
a change in ATP production in high glucose after a short incubation period. Our
preliminary data are indictive of a reduction in ATP concentrations following 24 hours of
high glucose. Similarly, Devi et al. (2010) demonstrates an intracellular ATP decrease of
20% in high glucose conditions (25 mM) compared to normal controls (5.5 mM) [10].
These combined data suggest that after stress insult, mitochondrial function decreases
from 6 to 24 hours. After 1 week, mitochondrial further decreases. With exposure to high
glucose conditions for 24 hours, cellular stress is further reflected via decreased
mitochondrial function, and after 1 week of exposure to high glucose, mitochondrial
function is severely disrupted functioning at a quarter of its capacity.
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Our studies evaluated the acute effects of high glucose exposure in retinal Müller cells
whereas the majority of studies examining the cytotoxic actions of high glucose in retinal
Müller cells have measured chronic effects manifested 4-7 days after exposure to high
glucose.

The findings of the chronic exposure studies have provided evidence for

sustained increases in ROS production, disruption of mitochondrial bioenergetics,
mitochondrial fragmentation and cell death.

We measured ROS concentrations after 24 hours in high glucose conditions. We found
that in as little as 24 hours, intracellular ROS increases in Müller cells when exposed to
glucose (n=3, p<0.001). We measured a 50% increase in ROS concentrations post-high
glucose exposure; indicating that ROS generation and mitochondrial dysfunction are
prominent and early components DR pathology. Studies in human Müller cells, Zhang et
al. (2018) showed that ROS increases by 40% after 6 hours of exposure to 100uM TBHP
[10]. TBHP exposure simulates mild oxidative stress conditions; mimicking DR-like
characteristics. Further, Tang et al. (2013) shows that after 4 days in high glucose (30
mM) conditions, superoxide increases by 101% and 119% in RGC and RPE cells,
respectively, compared to normal glucose controls (5 mM) (p<0.05) [36]. These combined
results suggest that from 6 hours of stress to 4 days, ROS is continually increasing.
However, to our knowledge, this is the first study to show that ROS increases significantly
in Müller cells after 24 hours of exposure to 25 mM glucose conditions.
The retina has a high need for antioxidant protection due to constant light exposure, high
oxygen consumption by photoreceptor cells and high concentrations of polyunsaturated
fatty acids in the outer segments [48]. In addition, the outer retina experiences circadian
55

periods of hypoxia (dark) and hyperoxia (light) that add to retinal oxidative stress [48].
Müller glial cells produce the key antioxidant, glutathione.

Glutathione is primarily

responsible for maintenance of redox balance in the retina [2, 3]. Glutathione status is
generally expressed as the ratio of reduced GSH to oxidized glutathione (GSSG). An
increased GSH:GSSG ratio reflects greater concentrations of reduced GSH than oxidized
GSSG indicative of an abundance of reducing power. Total glutathione, GSH and GSSG
concentrations were determined using a sensitive enzyme recycling assay (Cayman
Chemical, Ann Arbor, MI) first reported by Tietze [60].

Figure 15: Mechanism of Cayman Chemical Glutathione Recycling Assay. Tietze,

1969

We hypothesized that reduced GSH would be oxidized the GSSG under high glucose
conditions and that 670 nm light treatment would attenuate this oxidation. However, we
experienced difficulty with this assay and our results showed too much irregularity to be
interpreted. Because GSH is such a sensitive molecule, it is easily oxidized to the GSSG
form. During experiment, there is much manipulation and time required to measure GSH
and may therefore be oxidized or degraded. Additionally, some samples were frozen mid56

experiment. The thawing process during experiment may have also contributed to the
degradation of GSH.
Other studies have demonstrated that the GSH:GSSG ratio in DR pathogenesis may be
variable [3, 10, 19, 23, 55, 56, 57]. Lu et al. (1999) exhibits similar findings to our data
where GSH was increased in cultured Müller cells under the effects of mild oxidative
stress induced by butylhydroquinone [19]. After 12 hours, GSH was increased by 77%
compared to normal conditions. In the same study, Müller cells were exposed to 28 mM
high glucose conditions for 1 week. Müller cells in these high glucose conditions showed
a decrease in GSH by 30% compared to cells grown in 5.5 mM glucose conditions [19].
These results together are in agreement with data shown in the present study. GSH may
increase initially as a normal survival mechanism with the introduction of early oxidative
stress after 24 hours. However, after continued stress, GSH becomes depleted due to
the burden of ROS [6, 19, 51].
B. Effect of 670 nm Photobiomodulation in the retinal Müller cell Model of DR.
Novel to the present study, the mechanism of action of PBM utilizing 670 nm light in Müller
cells was studied after 24 hours under high glucose conditions. One-hour post-PBM
treatment, cells were assessed for mitochondrial function and ROS production. We found
that after treatment with 670 nm light, mitochondrial metabolic activity post exposure to
high glucose increased by 20%, however, this increase was not found to be significantly
different from Müller cells grown in high glucose conditions alone (n=3). With a p value of
0.09, it may be possible that if additional sample groups were added, this difference may
become significant. Additionally, one of the N of 3 shows that in high glucose conditions
did not decrease as much as our other samples, providing the large error bar found in our
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results. Similarly, the increase after treatment with light did not show as large of an
increase. Therefore, sample size may contribute to these results. However, with our
current data, it is important to recognize that our findings show that just one treatment
with 670 nm light has a beneficial effect on DR-affected mitochondria in Müller cells with
only a 15% decrease from normal conditions.
Further studies suggest that multiple light treatments may be necessary to reach the full
potential of PBM and therefore, significance.
In the current study, when Müller cells in high glucose were treated one time with 670 nm
light at 24 hours, mitochondrial membrane potential was completely restored to values
seen in normal glucose sham conditions (n=3, p<0.0001). These results show that high
glucose damages Müller cells via disrupted mitochondrial membrane potential after a very
short incubation period. However, one treatment with light was able to significantly
improve the mitochondrial membrane potential.
Interestingly, Müller cells in normal glucose conditions and treated with 670 nm light
showed a 20% decrease in mitochondrial membrane potential values from cells grown in
the normal glucose sham conditions; suggesting that PBM disrupts mitochondria in
normal conditions (n=3, p<0.05). Although unexpected, this could possibly be a result of
one assay among the three that showed a larger decrease than the others. Similarly, in
the context of all mitochondrial assays, mitochondrial function does not seem to be
different in normal glucose with PBM. Because Müller cells have a high degree of
metabolic activity, these cells may be particularly responsive to light. However, it is
important to note that Müller cells grown in this normal glucose, light treated conditions
still had significantly more functional mitochondria than cells in the high glucose disease
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conditions, as determined by the difference in mitochondrial membrane potential (n=3,
p<0.01).
Few studies have demonstrated changes in mitochondrial membrane potential in a DRmodel after 24 hours of glucose exposure. However, Zungu et al. (2008) shows that
fibroblasts suffer a disrupted mitochondrial membrane potential after exposure to hypoxic
and acidic conditions (95% N2 and 5% O2, pH 6.7) by 15% after 4 days. However, with
treatments on day 1 and 4 (2 total treatments), 632.8 nm helium-neon laser (3mW/cm2,
5J/cm2), mitochondrial membrane potential was significantly restored by an 10% and 18%
change from stressed conditions.
In our study, one light treatment with 670 nm light intervened in this DR pathway and
manipulated ATP levels, increasing trends to concentrations to those seen in the normal
glucose sham conditions. Increased levels of ATP due to light treatment is also
suggestive of improved ETC function. As a result of light, electron transfer is restored
promoting mitochondrial membrane potential and therefore, metabolic activity. Similarly,
Tang et al. showed that retinal superoxide increased by 50% in RGC cells after 4-day
exposure to 30 mM glucose conditions [36]. After 4 days of high glucose exposure and 8
total light treatments (670 nm, 25mw/cm2, 5J/cm2), ROS levels decreased by 50% with a
p value <0.05, showing concentrations similar to the normal glucose sham. Our combined
results suggest that ROS increases at 24 hours and stays elevated through day 4 [36].
Therefore, treatment with light is shown to decrease ROS to normal levels early in disease
pathogenesis as well as 4 days after high glucose insult.
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Novel to the study, our results suggest that just one treatment using 670 nm light
modulates our DR-signaling pathway through the improvement of mitochondrial function
and decreasing oxidative stress at the short time period of 24 hours post high glucose
treatment (n=3, p<0.001).
PBM treatment reversed these effects in our study and other DR models [36]. Therefore,
we conclude that PBM is a beneficial treatment to prevent these early factors in DR
pathogenesis, and novel to our study, we show that PBM may have the potential to be
utilized as an early intervention in DR pathogenesis.
We experienced practical difficulties in the analysis of GSH and GPx activity in this study.
Both of these assays may require a higher density of cells to distinguish between our
different groups. Future studies will need to be conducted to resolve this issue.

Summary, Conclusions and Clinical Significance.
In summary we provide evidence that a single-treatment with 670 nm light rapidly
attenuates high glucose-induced mitochondrial dysfunction and oxidative stress at 24
hours; culminating in inhibition of NFκB activation and a reduction in the production of
angiogenic and pro-inflammatory mediators in a cellular model of diabetic retinopathy.
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Figure 16: 670 nm Light Intervention in a DR pathway in Müller Cells Exposed
to High Glucose Conditions

Our data strongly supports our hypothesis that 670 nm photobiomodulation attenuates
hyperglycemia-induced mitochondrial dysfunction and protects against oxidative stress in
a rat Müller glial cell model of diabetic retinopathy.

Our findings also improve our

understanding of the acute effects of hyperglycemia in the retina and the potential of 670
nm PBM to ameliorate these effects.

This early interplay between mitochondrial dysfunction, ROS production and depleted
glutathione induced by high glucose conditions determine the heath and homeostasis of
the cell in DR. If left untreated, this pathogenic cell signaling continues resulting in
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blindness. Our data indicate that early intervention in this process using light therapy has
the potential to slow the course of diabetic retinopathy or possibly even prevent it.
Our in vitro model of DR has considerable potential for use in development and testing of
therapeutic agents to treat DR. The DR pathway in our Müller cell model suggested that
after one treatment with PBM, high glucose-induced mitochondrial dysfunction and ROS
generation was reversed after early exposure to stress. Therefore, the early interventions
of PBM on the pathogenesis of DR presented in this study demonstrate that light
treatment may be a potential beneficial tool in the early amelioration of diabetic
retinopathy.
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